Developing and executing commercialization strategies to leverage the proprietary and unique properties of our imine-linked polymer and composite derivations thereof for the transportation segment.Led strategy to reduce technology risk through non-dilutive financing - raising a total of $3.5M from the Colorado Office of Economic Development and International Trade, the National Science Foundation SBIR program (Phase I and Phase II), and the Cyclotron Road incubator, and the DOE. Led Mallinda's $2M series A Strategic Financing.

Mallinda was awarded its first Phase I NSF SBIR grant for the development of end user-moldable advanced polyimine composite inputs for the athletic protective gear market. I oversaw and administered the execution of the the company's Phase I objectives; completing the project on time and on budget.

Focusing on Entrepreneurship and Finance.

• Performed due diligence on 3 strategic acquisition targets valued at $508 million• Performed due diligence on distressed company for potential vertical integration• Drafted response to Request for Proposal for acquisition and worked with Corp Dev team through first and second round diligence and negotiations• Drafted presentation decks for CEO and CFO regarding strategic opportunities• Modeled sensitivity analysis on variables related to potential IPO, including float to raise, primary and secondary share sales, and timing• Assisted in analyzing potential refinancing of $1.25 billion of debt

Diligence market research relating to medical device space

- Processing, filing and prosecuting patents. - Brief writing for infringement litigation. - Patent search, infringement analysis, freedom to operate analysis, investigation of patent infringement.- Evaluating IP for potential market value and approaching and communicating with potential licensing partners.

Performing research in Dr. Karl Pfeifer's laboratory to study the regulatory mechanisms of genomic imprinting.